$29.84−1.49 (−4.76%)
At close: Nov 17, 2026, 4:00 PM ET· NYSE · USD
Oscar Health (OSCR) Income Statement
Is this a real, growing, cash-generative business, or a story propped up by accounting?
Sources Company filings FilingsHow we compute thisNot investment advice
6 figures withheld by our checks. Each blank figure names its reason.
Business engineGrowing fast: revenue compounds ~58.8%/yr (FY21→FY25), net margin −3.8%. Worth your attention in FY25: Share count (+46.6%). Visible in the receipts below.
The four lines that matter · FY21–FY25
Revenue ($M)▲27.5%
11,701.4
FY21→FY25CAGR +58.8%/yr
Net income ($M)—
−443.2
one-off year: see footnoteCAGR —
Free cash flow ($M)▲11.4%
1,058.5
FY21→FY25CAGR —
Diluted EPS—
−1.69
FY21→FY25CAGR —
What the receipts whisper · what a headline number hides
Share count
+46.6%
179.0mn → 262.4mn diluted shares since FY21. Rising share count dilutes EPS. Growth must outrun it.
Capex
$36.4M
+30.4% YoY in FY25 · 0.3% of revenue.
What the income statement says · FY21–FY25
Where every revenue dollar goes · FY25 ($M)
-4¢ of every revenue dollar becomes profit.
Margin trend · direction beats level Gross Operating Net
Net margin -3.8% is below the sector median.
The receipt · income statement · FY21–FY25 USD millions except per-share & ratios · hover a line for its definition
The annual and quarterly statements are struck on share counts that differ by a factor of 0.7573, so per-share figures cannot be compared across the two tables. Each table's per-share figures are on its own share basis.
USD millions except per-share & ratios
| Line item | TTM † | FY25 | FY24 | FY23 | FY22 | FY21 | YoY | CAGR 21→25 |
|---|---|---|---|---|---|---|---|---|
| Revenue & profitability | ||||||||
Revenue | 17,471.9 | 11,701.4 | 9,177.6 | 5,862.9 | 3,963.6 | 1,838.7 | ▲27.5% | +58.8% |
Cost of revenue | 3,858.2 | 0.0 | 0.0 | 0.0 | 3,280.8 | 1,624.0 | — | — |
Gross profit | 13,613.8 | —A | —A | —A | 682.8 | 214.7 | — | — |
Selling, general & admin | 2,630.2 | 2,049.9 | 1,755.6 | 1,425.8 | 1,257.4 | 265.1 | ▲16.8% | +66.8% |
Total operating expenses | 12,676.8 | 12,097.8 | 9,120.3 | 6,098.5 | 1,272.7 | 759.2 | ▲32.6% | +99.8% |
Operating incomefeeds ROC rank | 937.0 | −396.4 | 57.3 | −235.6 | −589.9 | −544.5 | — | — |
Other income, net | −32.5 | −40.9 | −23.8 | −31.7 | −20.2 | −26.1 | — | — |
Pretax income | 904.5 | −437.3 | 33.4 | −267.3 | −610.1 | −570.6 | — | — |
Income tax | 48.8 | 5.6 | 7.3 | 3.3 | −0.5 | 0.8 | ▼23.3% | +60.4% |
Net incomePiotroski ROA ✕feeds Buffett Quality owner earnings | 855.5 | −443.2 | 25.4 | −270.7 | −606.3 | −571.4 | — | — |
| Per share | ||||||||
Diluted EPSbuyback-sensitive | 2.47 | −1.69 | 0.10 | −1.22 | −2.85 | −3.20 | — | — |
Diluted shares (mn) | 346.46 | 262.39 | 265.85 | 221.66 | 212.47 | 178.97 | ▼1.3% | +10.0% |
| Margins | ||||||||
Gross margin71st pct in Healthcare | 77.9% | —A | —A | —A | 17.2% | 11.7% | — | — |
Operating margin | 5.4% | −3.4% | 0.6% | −4.0% | −14.9% | −29.6% | ▼4.0pp | +26.2pp |
Net margin55th pct in Healthcare | 4.9% | −3.8% | 0.3% | −4.6% | −15.3% | −31.1% | ▼4.1pp | +27.3pp |
† TTM = trailing four quarters through 2026-09-30.FY24 effective tax rate was 22% vs a −0% norm for this window, likely a one-time item; see the filing.A Withheld: cost of revenue is not on file, so the gross margin is not measured.
2 more years of statements and CSV export are on Premium.Premium · $119/yr · 7-day trial · cancel anytimeUnlock with Premium →
These lines feed the tenet checklists: see which gates passTenets →Margins & returns continue as sector-ranked ratiosStatistics →
Annual report filed 2026-02-13 · view filings on SEC EDGAR ↗ · reported currency USD · as-filed figures may be later restated.
Statements normalized in our fundamentals DB · Not investment advice.
Statements normalized in our fundamentals DB · Not investment advice.
Common questions
What was Oscar Health's revenue last fiscal year?
Oscar Health reported revenue of $11,701.4M in fiscal 2025, up 27.5% from fiscal 2024.
What was Oscar Health's net income?
Oscar Health reported net income of −$443.2M in fiscal 2025, a net margin of −3.8%.
Annual and quarterly statements as filed, normalized into one comparable shape · Not investment advice.

